Login / Signup

Reply to letter to the editor: "5-year follow-up results of a JCOG1104 (OPAS-1) phase III noninferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer".

Takaki YoshikawaMasanori TerashimaJunki Mizusawa
Published in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2024)
Keyphrases
  • phase iii
  • open label
  • clinical trial
  • phase ii
  • double blind
  • placebo controlled
  • study protocol
  • randomized controlled trial